Shuttle Pharmaceuticals Holdings, Inc. - common stock (SHPH)

Frequently Asked Questions About Shuttle Pharmaceuticals Holdings, Inc. - common stock (SHPH)

Has Shuttle Pharmaceuticals received any funding or investment?

Yes, Shuttle Pharmaceuticals has secured funding through various financing rounds to support its research and development efforts. Investments typically aim to facilitate the progression of their clinical pipelines, expanding their operational capabilities and innovation efforts.

How can investors learn more about Shuttle Pharmaceuticals?

Investors seeking more information about Shuttle Pharmaceuticals can visit the company's official website where they can access investor relations materials, including press releases, financial reports, and upcoming events. Additionally, regulatory filings with the SEC can provide deeper insights into the company’s financial health.

How does Shuttle Pharmaceuticals contribute to cancer research?

Shuttle Pharmaceuticals contributes to cancer research by developing novel therapeutic options and engaging in collaborations with academic and industry partners to advance understanding and treatment of cancer. Their research efforts aim to improve patient care and outcomes in oncology.

How does Shuttle Pharmaceuticals ensure the quality of its products?

Shuttle Pharmaceuticals implements rigorous quality control protocols throughout the development and manufacturing processes of its drug products. These measures are designed to meet regulatory standards and ensure that their therapies are safe and effective for patient use.

How does Shuttle Pharmaceuticals impact patients' lives?

Shuttle Pharmaceuticals aims to positively impact patients' lives by providing innovative cancer therapies that can enhance treatment efficacy while potentially reducing the side effects associated with traditional treatments. The company’s mission is to improve the quality of life for cancer patients through its research.

How does Shuttle Pharmaceuticals' approach differ from traditional cancer therapies?

Shuttle Pharmaceuticals aims to create more effective treatment options through innovative drug formulations that can optimize dosing and enhance therapeutic effects. Their approach is to build on existing therapies while improving patient outcomes and reducing adverse effects.

Is Shuttle Pharmaceuticals involved in clinical trials?

Yes, Shuttle Pharmaceuticals is actively engaged in conducting clinical trials for its drug candidates. These trials are crucial for substantiating the safety and efficacy of their treatments before they can obtain necessary regulatory approvals for wider clinical use.

Is Shuttle Pharmaceuticals publicly traded?

Yes, Shuttle Pharmaceuticals Holdings, Inc. is publicly traded on the Nasdaq stock exchange under the ticker symbol SHPH. The company has made efforts to expand its presence in the financial markets to support its research and development initiatives.

What are some of the key products in Shuttle Pharmaceuticals' pipeline?

Shuttle Pharmaceuticals is known for its innovative product pipeline, which includes prescription treatments that target various forms of cancer. The company is actively researching and developing formulations aimed at enhancing the effectiveness of existing therapies and managing the side effects of cancer treatment.

What are the risks associated with investing in Shuttle Pharmaceuticals?

Like any investment in a clinical-stage biopharmaceutical company, investing in Shuttle Pharmaceuticals entails risks such as the potential failure of drug development processes, regulatory hurdles, and market competition. Investors should carefully assess these risks and consult financial professionals before investing.

What does Shuttle Pharmaceuticals Holdings, Inc. do?

Shuttle Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for cancer treatment. The company specializes in the development of novel drug formulations and delivery systems that integrate advanced pharmaceutical technologies to enhance the efficacy of existing cancer treatments.

What future plans does Shuttle Pharmaceuticals have?

Looking ahead, Shuttle Pharmaceuticals plans to expand its clinical development efforts, continue innovating in cancer therapeutics, and explore additional partnerships to bolster its research capabilities. The company is also focused on potential market launches of their successful drug candidates.

What is the primary focus area of Shuttle Pharmaceuticals?

The primary focus of Shuttle Pharmaceuticals is on cancer therapeutics. The company aims to enhance current cancer treatment methodologies by developing compounds that can potentially improve efficacy and reduce side effects associated with traditional therapies.

What milestones has Shuttle Pharmaceuticals achieved?

Shuttle Pharmaceuticals has achieved several important milestones, including advancements in their clinical trials, partnerships with research institutions, and successful funding rounds. These milestones reflect the company's progress in developing innovative cancer therapies.

What partnerships does Shuttle Pharmaceuticals have?

Shuttle Pharmaceuticals often collaborates with academic institutions, research organizations, and industry partners to leverage expertise and resources for the development of its drug candidates. Partnerships are vital for enhancing research efforts and expanding clinical development capabilities.

What regulatory approvals does Shuttle Pharmaceuticals need?

Shuttle Pharmaceuticals must obtain several regulatory approvals from agencies like the U.S. Food and Drug Administration (FDA) for its drug candidates. This involves extensive clinical testing, data submission, and compliance with regulatory standards to ensure safety and efficacy before products can be marketed.

When was Shuttle Pharmaceuticals founded?

Shuttle Pharmaceuticals was founded in 2019, with an aim to innovate cancer treatment through its proprietary technologies and research initiatives, driven by a dedication to improving patient outcomes.

Where is Shuttle Pharmaceuticals headquartered?

Shuttle Pharmaceuticals Holdings, Inc. is headquartered in Rockville, Maryland. This location positions the company strategically within a hub of biotechnology research and development, allowing for collaboration and growth opportunities within the industry.

Who are the key executives at Shuttle Pharmaceuticals?

Shuttle Pharmaceuticals has an experienced team of executives with diverse backgrounds in pharmaceuticals, finance, and biomedicine. This includes a leadership team that has a proven track record in clinical development and regulatory affairs, guiding the company toward achieving its strategic goals.

What is the current price of Shuttle Pharmaceuticals Holdings, Inc. - common stock?

The current price of Shuttle Pharmaceuticals Holdings, Inc. - common stock is 0.4002

When was Shuttle Pharmaceuticals Holdings, Inc. - common stock last traded?

The last trade of Shuttle Pharmaceuticals Holdings, Inc. - common stock was at 3:55 pm EDT on April 3rd, 2025